Congruent results were noted to ascertain the antidiabetic effect on Streptozotocin (STZ)-induced type 2 diabetic mice based on weight loss prevention and improvements in fasting blood glucose and insulin levels [99,100]. This evidence concerns the gene INS and type 2 diabetes mellitus.